StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
26
Publishing Date
2022 - 10 - 13
1
2022 - 08 - 01
1
2022 - 07 - 25
1
2022 - 07 - 18
1
2022 - 06 - 06
1
2022 - 05 - 02
1
2022 - 04 - 20
1
2022 - 02 - 17
1
2022 - 02 - 14
1
2022 - 02 - 07
1
2021 - 11 - 10
1
2021 - 11 - 09
1
2021 - 11 - 03
1
2021 - 11 - 02
1
2021 - 10 - 12
1
2021 - 09 - 27
1
2021 - 09 - 23
1
2021 - 09 - 16
1
2021 - 07 - 28
1
2021 - 05 - 14
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 05
1
2021 - 02 - 22
1
2021 - 02 - 04
1
Sector
Finance
1
Health technology
26
Tags
Agtc-501
1
Aβos
1
Biotech-beach
1
Biotechnology
1
Ces
1
Clinical-trials-phase-ii
1
Conference
3
Disease
1
Earnings
1
Events
3
Financial results
13
Gene therapies
2
Gene therapy
2
N/a
17
Oto-313
1
Oto-413
2
Phase 1
1
Phase 2
2
Phase 2b
1
Phase 3
1
Positive
1
Pre-clinical
2
Preclinical
2
Presentation
2
Report
3
Research
2
Results
25
Therapy
2
Topline
2
Treatment
1
Trial
5
Trial results
1
Update
2
Entities
Applied genetic technologies corporation
10
Hercules capital, inc.
1
Otonomy, inc.
26
Symbols
ABBV
92
AEM
51
ALNY
81
AMGN
55
APO
41
ARVL
197
AUY
47
BAM
54
BGNE
52
BMO
41
BMY
73
BNPQF
82
BNPQY
82
BNTX
54
BTG
44
CHRS
48
CYTK
44
DAO
46
ENB
42
FBIO
61
FNCTF
374
FRBA
95
GILD
55
GMAB
48
GOLD
50
INCY
77
IONS
43
JD
43
JKS
42
JNJ
248
LGND
46
LLY
219
LTUM
61
LXRX
41
MDT
45
MDWD
53
MPC
55
MPLX
53
MS
225
NEE
49
NEP
48
NTES
59
NVS
59
NVSEF
44
PAYD
198
PFE
64
PPRUF
89
PPRUY
89
PRVB
46
REGN
88
SNY
393
SNYNF
315
TAK
71
TEVJF
53
TK
49
TNK
48
TTOO
44
UAN
52
XNCR
42
XYF
104
Exchanges
Nasdaq
26
Nyse
1
Crawled Date
2022 - 10 - 13
1
2022 - 08 - 01
1
2022 - 07 - 26
1
2022 - 07 - 18
1
2022 - 06 - 06
1
2022 - 05 - 02
1
2022 - 04 - 20
1
2022 - 02 - 17
1
2022 - 02 - 14
1
2022 - 02 - 07
1
2021 - 11 - 10
1
2021 - 11 - 09
1
2021 - 11 - 03
1
2021 - 11 - 02
1
2021 - 10 - 12
1
2021 - 09 - 27
1
2021 - 09 - 23
1
2021 - 09 - 16
1
2021 - 07 - 28
1
2021 - 05 - 14
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 05
1
2021 - 02 - 22
1
2021 - 02 - 04
1
Crawled Time
00:00
1
12:00
11
12:03
1
12:15
3
12:20
1
12:30
1
13:00
3
14:00
1
17:00
1
21:00
2
22:00
1
Source
www.biospace.com
9
www.globenewswire.com
17
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
results
symbols :
Otic
save search
Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss
Published:
2022-10-13
(Crawled : 13:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-70.24%
|
O:
-57.71%
H:
0.0%
C:
0.0%
oto-413
results
Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus
Published:
2022-08-01
(Crawled : 12:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-94.68%
|
O:
-74.57%
H:
16.16%
C:
-21.27%
oto-313
trial
results
phase 2
Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published:
2022-07-25
(Crawled : 00:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.0%
|
O:
4.39%
H:
0.0%
C:
0.0%
update
results
Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update
Published:
2022-07-18
(Crawled : 12:00)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-96.37%
|
O:
0.94%
H:
1.86%
C:
-0.47%
report
update
results
AGTC to Present Three-Month Interim Results from the SKYLINE Clinical Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa at the 45th Macula Society Annual Meeting
Published:
2022-06-06
(Crawled : 17:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.05%
|
O:
2.04%
H:
2.5%
C:
-1.5%
AGTC
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-56.23%
|
O:
2.06%
H:
0.24%
C:
-1.95%
agtc-501
treatment
trial
Otonomy to Report First Quarter 2022 Financial Results and Provide Corporate Update
Published:
2022-05-02
(Crawled : 12:20)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.56%
|
O:
-3.11%
H:
6.42%
C:
5.05%
report
results
Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss
Published:
2022-04-20
(Crawled : 12:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.45%
|
O:
0.92%
H:
15.45%
C:
4.09%
oto-413
trial
positive
results
topline
phase 2b
Otonomy to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update
Published:
2022-02-17
(Crawled : 13:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.31%
|
O:
0.0%
H:
1.67%
C:
-3.33%
financial results
report
results
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2021
Published:
2022-02-14
(Crawled : 12:30)
- globenewswire.com
HTGC
F
|
$18.46
1.15%
0.38%
660K
|
Finance
|
2.43%
|
O:
-0.34%
H:
0.62%
C:
-0.28%
OTIC
|
$0.077
|
Health Technology
|
-96.13%
|
O:
1.5%
H:
2.46%
C:
0.99%
AGTC
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-84.06%
|
O:
-6.48%
H:
8.01%
C:
6.06%
financial results
ces
results
AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 14, 2022
Published:
2022-02-07
(Crawled : 14:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.13%
|
O:
-0.5%
H:
2.51%
C:
2.01%
AGTC
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-80.71%
|
O:
5.39%
H:
4.65%
C:
1.86%
financial results
conference
results
Otonomy Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published:
2021-11-10
(Crawled : 22:00)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-96.35%
|
O:
-0.94%
H:
0.0%
C:
0.0%
AGTC
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-84.26%
|
O:
-1.2%
H:
0.0%
C:
0.0%
financial results
results
AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2021
Published:
2021-11-09
(Crawled : 12:15)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-96.31%
|
O:
1.43%
H:
0.0%
C:
0.0%
AGTC
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-85.66%
|
O:
0.55%
H:
0.0%
C:
0.0%
financial results
results
Otonomy to Report Third Quarter 2021 Financial Results and Provide Corporate Update
Published:
2021-11-03
(Crawled : 12:15)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.33%
|
O:
2.37%
H:
1.85%
C:
-1.85%
financial results
results
AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 9, 2021
Published:
2021-11-02
(Crawled : 12:00)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-96.32%
|
O:
0.24%
H:
0.0%
C:
0.0%
AGTC
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-85.06%
|
O:
3.61%
H:
1.83%
C:
0.73%
financial results
results
conference
Otonomy Announces Publication of Phase 1/2 Trial Results Showing Tinnitus Improvement in Patients Receiving OTO-313
Published:
2021-10-12
(Crawled : 12:00)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-95.55%
|
O:
0.0%
H:
3.45%
C:
0.0%
phase 1
results
trial
trial results
phase 2
Otonomy Announces Presentation of OTO-413 Clinical Results at AAO-HNS Annual Meeting
Published:
2021-09-27
(Crawled : 12:00)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-95.77%
|
O:
-3.28%
H:
10.73%
C:
9.6%
presentation
results
aβos
AGTC Provides Financial Results for the Fourth Quarter and Year Ended June 30, 2021
Published:
2021-09-23
(Crawled : 21:00)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-95.84%
|
O:
-1.61%
H:
0.0%
C:
0.0%
AGTC
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-88.49%
|
O:
-3.8%
H:
0.0%
C:
0.0%
financial results
results
AGTC to Host Fourth Quarter and 2021 Fiscal Year End Financial Results Conference Call and Webcast on September 23, 2021
Published:
2021-09-16
(Crawled : 12:15)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-95.16%
|
O:
0.63%
H:
1.24%
C:
1.24%
AGTC
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-87.93%
|
O:
0.0%
H:
3.99%
C:
2.45%
financial results
results
conference
Otonomy to Report Second Quarter 2021 Financial Results and Provide Corporate Update
Published:
2021-07-28
(Crawled : 12:00)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-95.58%
|
O:
-0.57%
H:
3.45%
C:
0.57%
financial results
results
Otonomy and AGTC Present Preclinical Proof-of-Concept Results for OTO-825 Gene Therapy at ASGCT Annual Meeting
Published:
2021-05-14
(Crawled : 12:00)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-96.31%
|
O:
-0.48%
H:
7.66%
C:
-0.96%
AGTC
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-89.28%
|
O:
2.45%
H:
3.72%
C:
3.19%
gene therapy
therapy
results
gene therapies
preclinical
pre-clinical
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.